Stock Information
Mirum Pharmaceuticals Inc (MIRM)
Ticker Symbol: MIRM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $4,743.11 mil
Piotroski score: 6
PE Ratio: N/A
EPS (TTM): -0.4783
Revenue (TTM): $10.12 M
Dividend Yield: N/A%
ROE: -8.53%
Latest News
-
Leerink Partners Maintains Outperform on Mirum Pharmaceuticals, Lowers Price Target to $118
Thu, Feb 26, 2026 3:39 PM
-
TD Cowen Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $117
Thu, Feb 26, 2026 2:12 PM
-
13 Analysts Have This To Say About Mirum Pharmaceuticals
Thu, Feb 26, 2026 2:01 PM
-
RBC Capital Maintains Outperform on Mirum Pharmaceuticals, Lowers Price Target to $128
Thu, Feb 26, 2026 11:43 AM
-
Citizens Maintains Market Outperform on Mirum Pharmaceuticals, Lowers Price Target to $132
Thu, Feb 26, 2026 10:51 AM
-
Stifel Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $125
Thu, Feb 26, 2026 10:35 AM
-
Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals)
Thu, Feb 26, 2026 9:23 AM
-
Mirum Pharmaceuticals (NASDAQ:MIRM) Reports Q4 2025 Revenue Beat and 2026 Outlook
Wed, Feb 25, 2026 11:20 PM
-
Mirum Pharmaceuticals, Inc. (MIRM) Q4 2025 Earnings Call Transcript
Wed, Feb 25, 2026 6:37 PM
-
Mirum Pharmaceuticals Sees FY2026 Sales $630.000M-$650.000M vs $638.367M Est
Wed, Feb 25, 2026 5:15 PM
Key Financials
Financial data not available
